Haematologic Technologies, Inc. (HTI) is a primary manufacturer who specialises in the isolation and characterisation of high quality, plasma proteins which are intended for in vitro research use. HTI’s emphasis is focused on proteins involved in the coagulation cascade, as well as the regulation of bone metabolism.
The HTI product line consists of over 150 highly purified and well-characterised proteins including zymogens, enzymes, cofactors, and inhibitors as well as a complementary line of monoclonal and polyclonal antibodies.
Please Contact Us directly for price, availability or technical enquiries
For further information on the complete range of products from Haematologic Technologies, please visit them online.
